Article

Evaluation of potential adverse effects of gender-affirming hormonal therapy; findings from the Spanish Pharmacovigilance System Database

2024-12-19

Abstract excerpt

The Spanish Pharmacovigilance System for Medicines for Human Use (SEFV-H) is responsible for recording and evaluating adverse reactions suspected to be due to the medicines. The aim of this study was to review all reports of suspected adverse drug reaction (ADRs) in the SEFV-H database derived from the gender-affirming hormone therapy (GAHT). For this purpose, we consulted the Andalusian Centre for Pharmacovigilan...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 36427a05-acb7-56a3-b069-7fba9e1a5667
DOI: 10.22541/au.173458806.65026390/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluation of potential adverse effects of gender-affirming hormonal therapy; findings from the Spanish Pharmacovigilance System DatabaseDOI 10.22541/au.173458806.65026390/v1Read

Assessment of drug-induced adverse events reported for transgender population in IndiaSemantic proximity Read

Adverse drug reactions associated with the use of biological agentsSemantic proximity Read

An opportunity for clinical pharmacology trained physicians to improve patient drug safety: A retrospective analysis of adverse drug reactions in teenagersSemantic proximity Read

Real-world pharmacovigilance study of voclosporin based on FAERS and VigiBaseSemantic proximity Read

Adverse Events During Pregnancy Associated with Third Generation Antiseizure Medications: A Real-World AnalysisSemantic proximity Read

Safety assessment of S-1: Real-world adverse event analysis from the FAERS databaseSemantic proximity Read

Common Causes and Characteristics of Adverse Drug Reactions in Older Adults: A Retrospective StudySemantic proximity Read

Real-world safety profile of Enfortumab Vedotin: A comprehensive pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS)Semantic proximity Read

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for TivozanibSemantic proximity Read

Signal Mining and Analysis of Adverse Events of Isotretinoin: 20-year real-world pharmacovigilance analysis based on the FAERS databaseSemantic proximity Read

Research Progress on High-Risk Drugs for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Insights from Adverse Drug Reaction Database MiningSemantic proximity Read

Call to Action: Harmonisation of Pharmacovigilance Regulations for Post-marketing Pregnancy and Breastfeeding Safety StudiesSemantic proximity Read